TARGETING TRANSCRIPTIONAL ADDICTION FOR GBM THERAPY THROUGH CDK7 INHIBITION

被引：0

作者：

Meng, Wei ^{[1
]}

Wang, Jiajia ^{[1
]}

Li, Qifeng ^{[1
]}

Liu, Fang ^{[2
]}

Li, Meng ^{[2
]}

Jiang, Wenyan ^{[2
]}

Lin, Li ^{[3
]}

Dai, Xiaomin ^{[3
,4
]}

Wang, Hongxiang ^{[5
]}

Zhang, Chenran ^{[1
]}

Wang, Baocheng ^{[1
]}

Chen, Juxiang ^{[5
]}

Zhang, Liye ^{[3
]}

Tang, Yujie ^{[1
,2
]}

Ma, Jie ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ,Dept Pathophysiol, Shanghai, Peoples R China

[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

[4] Univ Chinese Acad Sci, Beijing, Peoples R China

[5] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TBIO-01

引用

页码：180 / 180

页数：1

共 50 条

[21] Linking cancer transcriptional addictions by CDK7 to YAP/TAZ
Piccolo, Stefano
GENES & DEVELOPMENT, 2020, 34 (1-2) : 4 - 6
[22] CDK7 INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA
Vitanza, Nicholas
Nagaraja, Surya
Woo, Pamelyn
Tang, Yujie
Monje, Michelle
NEURO-ONCOLOGY, 2016, 18 : 51 - 51
[23] The Mediator captures CDK7, an attractive transcriptional target in cancer
Wang, Yubao
Manokaran, Cherubin
Wu, Su
Roberts, Thomas M.
CANCER CELL, 2021, 39 (09) : 1184 - 1186
[24] Identification of a novel preclinical candidate for CDK7 inhibition
Satyam, Leena K.
Poddutoori, Ramulu
Mukherjee, Subhendu
Marappan, Sivapriya
Gopinath, Sreevalsam
Basavaraju, Aravind
Kaza, Lakshmi Narayana
Pothuganti, Manoj Kumar
Nayak, Shilpa
Nandish, C.
Ravindra, Amith A.
Babu, Dabbeeru Madhu
Nagaraju, A.
Tgore, Suraj
Antony, Thomas
Pandit, Chetan
Ramachandra, Murali
Chelur, Shekar
Daginakatte, Girish
Samajdar, Susanta
CANCER RESEARCH, 2017, 77
[25] Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition
Peng, Jingyu
Yang, Ming
Bi, Ran
Wang, Yueyuan
Wang, Chunxi
Wei, Xue
Zhang, Zhihao
Xie, Xiao
Wei, Wei
FRONTIERS IN ONCOLOGY, 2021, 11
[26] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Kwiatkowski, Nicholas
Zhang, Tinghu
Rahl, Peter B.
Abraham, Brian J.
Reddy, Jessica
Ficarro, Scott B.
Dastur, Anahita
Amzallag, Arnaud
Ramaswamy, Sridhar
Tesar, Bethany
Jenkins, Catherine E.
Hannett, Nancy M.
McMillin, Douglas
Sanda, Takaomi
Sim, Taebo
Kim, Nam Doo
Look, Thomas
Mitsiades, Constantine S.
Weng, Andrew P.
Brown, Jennifer R.
Benes, Cyril H.
Marto, Jarrod A.
Young, Richard A.
Gray, Nathanael S.
NATURE, 2014, 511 (7511) : 616 - +
[27] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski
Tinghu Zhang
Peter B. Rahl
Brian J. Abraham
Jessica Reddy
Scott B. Ficarro
Anahita Dastur
Arnaud Amzallag
Sridhar Ramaswamy
Bethany Tesar
Catherine E. Jenkins
Nancy M. Hannett
Douglas McMillin
Takaomi Sanda
Taebo Sim
Nam Doo Kim
Thomas Look
Constantine S. Mitsiades
Andrew P. Weng
Jennifer R. Brown
Cyril H. Benes
Jarrod A. Marto
Richard A. Young
Nathanael S. Gray
Nature, 2014, 511 : 616 - 620
[28] CDK7 INHIBITION EXHIBIT POTENT PRECLINICAL ANTITUMOR ACTIVITY IN CHOLANGIOCARCINOMA THROUGH INHIBITION OF GENE TRANSCRIPTION
Huang, Tianlu
Ding, Xiwei
Zou, Xiaoping
GASTROENTEROLOGY, 2019, 156 (06) : S1307 - S1308
[29] Selective inhibition of CDK7 ameliorates experimental arthritis in mice
Yong Xia
Li-Ying Lin
Mei-Ling Liu
Zheng Wang
Hong-Hai Hong
Xu-Guang Guo
Guo-Quan Gao
Clinical and Experimental Medicine, 2015, 15 : 269 - 275
[30] Starving multiple myeloma cells via CDK7 inhibition
Sacco, Antonio
Roccaro, Aldo M.
BLOOD, 2023, 141 (23) : 2787 - 2788

← 1 2 3 4 5 →